This inventor holds 151 USPTO granted patents and 63 published patent applications, plus 3 CIPO patents and 55 EPO patents, primarily in Pharmaceutical Compositions (CPC class A61K31-4985). Top assignees: Intra-Cellular Therapies, Inc., Qualcomm Incorporated, Takeda Pharmaceutical Company Limited. Active years: 2002-2026.
Inventors with similar research interests:
Location History:
- San Diego, CA (US) (2002 - 2017)
- New York, NY (US) (2012 - 2020)
- New Milford, NJ (US) (2012 - 2024)
Company Filing History:
135 out of 181 
12 out of 44,618 
3 out of 1,222 
Years Active: 2002-2026
Areas of Expertise:
Title: Peng Li: A Prolific Inventor and Innovator
Introduction:
In the world of patents and innovations, Peng Li stands out as a remarkable figure. Hailing from New Milford, NJ, Li has made significant contributions to the pharmaceutical industry through his numerous patents. This article explores his latest patents, career highlights, collaborations, and sheds light on his notable work.
Latest Patents:
Peng Li's recent patents demonstrate his expertise and innovative thinking in the medical field. Two noteworthy patents are:
1. Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate:
This patent focuses on pharmaceutical capsules comprising lumateperone, a potent therapeutic agent. These capsules can be used alone or in combination with other therapeutic agents for disease treatment and prevention. The patent encompasses the manufacturing processes and methods of use for this novel treatment approach.
2. Transmucosal methods for treating psychiatric and neurological conditions:
This patent reveals Li's contribution to the development of new pharmaceutical compositions. These compositions contain specific chemical compounds and facilitate transmucosal or subcutaneous administration. The invention addresses the treatment of psychiatric and neurological conditions, offering alternative routes for drug delivery.
Career Highlights:
Peng Li has an impressive record with over 100 patents to his name. He has dedicated his career to advancing medical treatments and exploring innovative pharmaceutical solutions. Two significant highlights of his career are:
1. Intra-cellular Therapies, Inc.:
Peng Li has worked for Intra-cellular Therapies, Inc., a renowned pharmaceutical company known for its commitment to developing novel therapies. During his tenure, he contributed to cutting-edge research projects and furthered the company's mission to improve patient outcomes.
2. Takeda Pharmaceutical Company Limited:
Li has also collaborated with Takeda Pharmaceutical Company Limited, a multinational pharmaceutical corporation. His expertise and innovative contributions have helped Takeda advance its research and development efforts, enhancing their product pipeline.
Collaborations:
Throughout his career, Peng Li has collaborated with distinguished professionals in the pharmaceutical industry. One notable coworker is Lawrence P Wennogle. Their collaboration has likely led to groundbreaking developments, further establishing Li's influence and expertise.
Conclusion:
Peng Li's journey as an inventor and innovator proves his dedication to pushing the boundaries of pharmaceutical treatments. With an extensive patent portfolio and diverse collaborations, he continues to make significant contributions to the medical field. Li's expertise and inventive mindset serve as an inspiration to fellow professionals and aspiring inventors seeking to make a difference in the healthcare industry.
Note: The information provided in this article is based on the given data. Additional research regarding Peng Li's patents, career, and collaborations would enhance the accuracy and depth of the content. This article is intended to offer an overview of his achievements and not an exhaustive account.